May 24 |
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
|
May 23 |
Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why
|
May 22 |
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
|
May 16 |
Insider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
|
May 14 |
Wall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet
|
May 10 |
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...
|
May 9 |
ALX Oncology reports Q1 results
|
May 9 |
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
May 7 |
ALX Oncology Appoints Allison Dillon as Chief Business Officer
|
Apr 30 |
ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
|